AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present at Smith Barney Citigroup Healthcare Conference and Lehman Brothers Global Healthcare Conference SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Smith Barney Citigroup Healthcare Conference on Wednesday, March 30, 2005 at 2:30 p.m. ET in Washington D.C. and at the Lehman Brothers Global Healthcare Conference on Friday, April 1, 2005 at 8:30 a.m. ET in Miami Beach, FL. Mark G. Foletta, Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview at the Smith Barney Citigroup conference. Ginger L. Graham, President & Chief Executive Officer of Amylin Pharmaceuticals, will be presenting at the Lehman Brothers conference. Both presentations will be webcast live, and recordings will be made available following each event. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentations to register and download any necessary audio software. Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director, Investor Relations of Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/

Copyright